| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.35B | 37.10B | 47.48B | 42.20B | 47.08B | 51.38B |
| Gross Profit | 13.67B | 13.37B | 11.62B | 10.52B | 13.35B | 16.30B |
| EBITDA | 3.82B | 4.77B | 5.04B | 4.31B | 6.96B | 9.80B |
| Net Income | 1.43B | 1.50B | 1.36B | 1.18B | 2.99B | 4.74B |
Balance Sheet | ||||||
| Total Assets | 39.81B | 37.87B | 38.26B | 33.94B | 36.92B | 35.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.61B | 3.90B | 2.80B | 1.06B | 3.72B | 3.78B |
| Total Debt | 16.36B | 17.16B | 18.61B | 17.89B | 19.05B | 20.05B |
| Total Liabilities | 25.27B | 25.34B | 26.65B | 23.53B | 26.44B | 26.41B |
| Stockholders Equity | 14.54B | 12.37B | 11.45B | 10.41B | 10.47B | 9.23B |
Cash Flow | ||||||
| Free Cash Flow | 2.24B | 3.31B | 2.85B | 168.00M | 3.04B | 4.47B |
| Operating Cash Flow | 4.30B | 5.52B | 5.32B | 3.10B | 5.61B | 8.20B |
| Investing Cash Flow | -2.03B | -2.25B | -3.36B | -3.00B | -2.55B | -3.69B |
| Financing Cash Flow | -2.39B | -2.16B | -227.00M | -2.77B | -3.11B | -5.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.77B | 12.33 | ― | 1.43% | 10.77% | 131.68% | |
74 Outperform | ¥14.92B | 24.48 | ― | 2.16% | 1.28% | 18.81% | |
73 Outperform | ¥53.18B | 8.14 | ― | 3.20% | 4.98% | -10.23% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥24.27B | 3.15 | ― | 1.87% | 3.06% | -53.49% | |
60 Neutral | ¥42.86B | 4.13 | ― | 1.52% | 6.00% | -45.34% | |
46 Neutral | ¥37.73B | 21.75 | ― | 1.65% | -1.17% | -84.81% |